|
Pathophysiology of Chemotherapy-Induced Cognitive Deficits in Juvenile Rats
|
1R01CA182284-01A1
|
$346,525
|
$346,525
|
COLE, PETER
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Core Support for Cancer Center
|
3P30CA013330-41S1
|
$75,000
|
$3,000
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Core Support for Cancer Center
|
3P30CA013330-41S2
|
$148,500
|
$5,940
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Core Support for Cancer Center
|
5P30CA013330-41
|
$3,585,248
|
$143,410
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Nemours NCI Community Oncology Research Program (NCORP)
|
1UG1CA189958-01
|
$1,040,214
|
$1,040,214
|
SANDLER, ERIC
|
ALFRED I. DU PONT HOSP FOR CHILDREN
|
|
Nemours Community Clinical Oncology Program
|
3U10CA176879-01S1
|
$89,460
|
$44,730
|
SANDLER, ERIC
|
ALFRED I. DU PONT HOSP FOR CHILDREN
|
|
Development of Transporter Targeted Platinum Drugs for Pediatric Tumor
|
1R43CA183186-01
|
$190,000
|
$190,000
|
MAMELOK, RICHARD
|
APRICITY THERAPEUTICS, INC.
|
|
Bay Area Tumor Institute CCOP
|
3U10CA045461-24S1
|
$81,028
|
$26,739
|
FEUSNER, JAMES
|
BAY AREA TUMOR INSTITUTE
|
|
Bay Area Tumor Institute NCORP
|
1UG1CA189817-01
|
$698,719
|
$174,680
|
GREIF, JON
|
BAY AREA TUMOR INSTITUTE
|
|
Redefining Langerhans Cell Histiocytosis as a Myeloid Dysplasia and Identifying B
|
5R01CA154489-04
|
$316,606
|
$316,606
|
ALLEN, CARL
|
BAYLOR COLLEGE OF MEDICINE
|
|
Improving T-cell therapies for neuroblastoma
|
5R01CA142636-05
|
$287,576
|
$287,576
|
DOTTI, GIANPIETRO
|
BAYLOR COLLEGE OF MEDICINE
|
|
Germline Telomere Biology Defects in Pediatric and Young Adult Acute Myeloid Leuk
|
5K23CA158148-03
|
$168,757
|
$168,757
|
GRAMATGES, MARIA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Enhancing T Cell Therapy of Cancer
|
5P01CA094237-12
|
$1,874,319
|
$468,580
|
HESLOP, HELEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
SPORE in Lymphoma
|
5P50CA126752-08
|
$2,162,000
|
$237,820
|
HESLOP, HELEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Identifying Cell Stress Proteins that Predict Clinical Response in Pediatric AML
|
3R01CA164024-02S1
|
$3,941
|
$3,941
|
HORTON, TERZAH
|
BAYLOR COLLEGE OF MEDICINE
|
|
Identifying Cell Stress Proteins that Predict Clinical Response in Pediatric AML
|
5R01CA164024-02
|
$322,104
|
$322,104
|
HORTON, TERZAH
|
BAYLOR COLLEGE OF MEDICINE
|
|
Cognitive Change after Proton RT vs. Photon or Surgery for Pediatric Brain Tumor
|
1R01CA187202-01
|
$636,476
|
$636,476
|
KAHALLEY, LISA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Neurocognitive Outcomes Following Proton Beam Radiation Therapy for Treatment of
|
5K07CA157923-04
|
$148,746
|
$148,746
|
KAHALLEY, LISA
|
BAYLOR COLLEGE OF MEDICINE
|
|
(PQD-5) Patient derived orthotopic xenograft models for drug response prediction
|
1R01CA185402-01
|
$324,033
|
$324,033
|
LI, XIONAN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Localization and Function of NKT Cells in Neuroblastoma
|
5R01CA116548-09
|
$227,424
|
$227,424
|
METELITSA, LEONID
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-08S1
|
$75,000
|
$15,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-08S3
|
$48,834
|
$9,767
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-08S4
|
$149,801
|
$29,960
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-08
|
$2,746,741
|
$549,348
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Role of the BMP SMADs in Oncogenesis
|
5R01CA138628-05
|
$343,739
|
$171,870
|
PANGAS, STEPHANIE
|
BAYLOR COLLEGE OF MEDICINE
|
|
Pediatric Oncology Clinical Research Training Program
|
3K12CA090433-13S1
|
$129,088
|
$129,088
|
POPLACK, DAVID
|
BAYLOR COLLEGE OF MEDICINE
|
|
Pediatric Oncology Clinical Research Training Program
|
5K12CA090433-13
|
$702,951
|
$702,951
|
POPLACK, DAVID
|
BAYLOR COLLEGE OF MEDICINE
|
|
Using Stat3 Signaling Profiles to Understand Chemotherapy Resistance in AML
|
1R01CA175026-01A1
|
$405,847
|
$405,847
|
REDELL, MICHELE
|
BAYLOR COLLEGE OF MEDICINE
|
|
Targeting the G-CSF/STAT3 signaling pathway in neuroblastoma cancer stem cells
|
1R01CA174808-01A1
|
$326,348
|
$326,348
|
SHOHET, JASON
|
BAYLOR COLLEGE OF MEDICINE
|
|
Training Program in Pediatric Cancer Epidemiology and Control
|
5R25CA160078-04
|
$516,699
|
$516,699
|
SPITZ, MARGARET
|
BAYLOR COLLEGE OF MEDICINE
|
|
The Role of Growth Factor Receptor Trafficking in Tumorigenesis
|
3R01CA166749-02S1
|
$51,202
|
$51,202
|
ZAGE, PETER
|
BAYLOR COLLEGE OF MEDICINE
|
|
The Role of Growth Factor Receptor Trafficking in Tumorigenesis
|
5R01CA166749-02
|
$309,346
|
$309,346
|
ZAGE, PETER
|
BAYLOR COLLEGE OF MEDICINE
|
|
Integrated models for metastatic phenotype and outcome prediction in osteosarcoma
|
1R01CA178908-01A1
|
$379,336
|
$189,668
|
SPENTZOS, DIMITRIOS
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
The pVHL/Jade-1/beta-catenin axis in renal cancer
|
3R01CA079830-13S1
|
$66,893
|
$66,893
|
COHEN, HERBERT
|
BOSTON MEDICAL CENTER
|
|
The pVHL/Jade-1/beta-catenin axis in renal cancer
|
5R01CA079830-13
|
$310,590
|
$310,590
|
COHEN, HERBERT
|
BOSTON MEDICAL CENTER
|
|
""Oncorequisite"" Genes in MYC-mediated Transformation
|
5R00CA134743-05
|
$234,037
|
$46,807
|
FENG, HUI
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Development of Novel Therapeutic Strategies in Human Leukemias
|
2P01CA066996-16A1
|
$2,307,647
|
$276,918
|
EBERT, BENJAMIN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Pathogenesis and Treatment of NUT-Midline Carcinoma
|
3R01CA124633-07S1
|
$37,260
|
$37,260
|
FRENCH, CHRISTOPHER
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Pathogenesis and Treatment of NUT-Midline Carcinoma
|
5R01CA124633-07
|
$284,179
|
$284,179
|
FRENCH, CHRISTOPHER
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Epstein-Barr Virus Nuclear Protein in B Cell Growth Transformation
|
5R01CA047006-27
|
$548,274
|
$274,137
|
KIEFF, ELLIOTT
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Epstein-Barr Virus LMP1-Mediated Oncogenecity
|
5R01CA085180-13
|
$680,363
|
$340,182
|
KIEFF, ELLIOTT
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Roles of Epstein-Barr virus nuclear antigens 2 and LP in B cell proliferation
|
5R01CA170023-02
|
$355,670
|
$177,835
|
KIEFF, ELLIOTT
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Engineering a supramolecular platinum nanoparticle for pediatric cancer
|
1R21CA186009-01
|
$215,682
|
$215,682
|
SENGUPTA, SHILADITYA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Defining novel drivers and predictive signatures of metastasis in osteosarcoma th
|
1F30CA186633-01
|
$44,604
|
$44,604
|
MORROW, JAMES
|
CASE WESTERN RESERVE UNIVERSITY
|
|
The Role of JAB1 in osteosarcoma pathogenesis
|
5R03CA175874-02
|
$76,873
|
$38,437
|
ZHOU, GUANG
|
CASE WESTERN RESERVE UNIVERSITY
|
|
COG NCTN Solid Malignancy Integrated Translational Science Center
|
1U10CA180884-01
|
$400,000
|
$400,000
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
1U10CA180886-01
|
$26,616,497
|
$26,616,497
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-01S1
|
$79,593
|
$79,593
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-01S2
|
$208,457
|
$208,457
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-01S3
|
$229,232
|
$229,232
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
Total relevant funding to Childhood Cancers for this search: $203,716,485
|